GOZZINI, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 2.042
EU - Europa 1.200
AS - Asia 611
SA - Sud America 72
AF - Africa 16
OC - Oceania 13
Totale 3.954
Nazione #
US - Stati Uniti d'America 2.021
RU - Federazione Russa 486
PL - Polonia 285
SG - Singapore 175
CN - Cina 163
HK - Hong Kong 112
IE - Irlanda 104
IT - Italia 92
SE - Svezia 87
BR - Brasile 57
KR - Corea 50
VN - Vietnam 36
DE - Germania 35
FR - Francia 29
FI - Finlandia 25
JO - Giordania 21
GB - Regno Unito 19
IN - India 17
CA - Canada 15
UA - Ucraina 14
AU - Australia 13
CH - Svizzera 13
ID - Indonesia 9
CI - Costa d'Avorio 6
MX - Messico 6
ZA - Sudafrica 6
AR - Argentina 5
BD - Bangladesh 5
TR - Turchia 5
JP - Giappone 4
VE - Venezuela 4
EC - Ecuador 3
NL - Olanda 3
BE - Belgio 2
BJ - Benin 2
ES - Italia 2
IL - Israele 2
IQ - Iraq 2
PK - Pakistan 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AZ - Azerbaigian 1
BH - Bahrain 1
CL - Cile 1
CO - Colombia 1
HU - Ungheria 1
IR - Iran 1
KE - Kenya 1
LT - Lituania 1
MM - Myanmar 1
NP - Nepal 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
TH - Thailandia 1
Totale 3.954
Città #
Santa Clara 582
Warsaw 285
Ashburn 188
Fairfield 154
Singapore 122
Chandler 114
Dublin 104
Hong Kong 94
Woodbridge 88
Seattle 83
Beijing 77
Cambridge 76
Houston 65
San Jose 51
Seoul 48
Wilmington 39
Ann Arbor 35
Buffalo 34
Lawrence 29
Princeton 29
Altamura 28
Paris 24
Florence 20
Los Angeles 20
Jacksonville 18
Shanghai 18
Munich 16
Boston 15
Medford 15
Melbourne 13
Bern 12
The Dalles 12
Kent 11
Moscow 11
Mumbai 11
Rome 11
San Diego 11
Clifton 10
Dong Ket 10
Boardman 9
New York 9
Redondo Beach 8
Dearborn 7
Ho Chi Minh City 7
Norwalk 7
Abidjan 6
Denver 6
Jakarta 6
Orem 6
Turin 6
Brooklyn 5
Dallas 5
Hanoi 5
Helsinki 5
Phoenix 5
Renton 5
Toronto 5
Frankfurt am Main 4
Notre Dame 4
Rio de Janeiro 4
Tokyo 4
Yubileyny 4
Cape Town 3
Detroit 3
Falls Church 3
Hillsboro 3
London 3
Malang 3
Milan 3
Montreal 3
Pune 3
São Paulo 3
Tappahannock 3
Tianjin 3
Turku 3
Andover 2
Ankara 2
Araraquara 2
Atlanta 2
Barcelona 2
Bremen 2
Brussels 2
Bình Dương 2
Cleveland 2
Columbus 2
Cotonou 2
Council Bluffs 2
Dalseong-gun 2
Erbil 2
Guayaquil 2
Izmir 2
Johannesburg 2
Karlskrona 2
Kochi 2
Macaé 2
Maracaibo 2
Mexico City 2
Montréal 2
Nuremberg 2
Piancogno 2
Totale 2.804
Nome #
Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine. 320
Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells 267
Severe hypoxia selects hematopoietic progenitors with stem cell potential from primary Myelodysplastic syndrome bone marrow cell cultures. 242
In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features 202
Mutated ASXL1 and number of somatic mutations as possible indicators of progression to chronic myelomonocytic leukemia of myelodysplastic syndromes with single or multilineage dysplasia 196
Redistribution of H3K27me3 and acetylated histone H4 upon exposure to azacitidine and decitabine results in de-repression of the AML1/ETO target gene IL3. 195
Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells 177
Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine 174
Acetylome and phosphoproteome modifications in imatinib resistant chronic myeloid leukaemia cells treated with valproic acid. 173
Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO positive leukemia cells 167
Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine. 164
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients. 158
Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib 154
Salarin C inhibits maintenance of hypoxia-selected Chronic Myeloid Leukemia progenitor cells 147
Complete remission with brentuximab vedotin in a case of primary cutaneous gamma-delta T-cell lymphoma relapsed after allogeneic stem cell transplantation 134
MAPKS ARE INVOLVED IN THE SURVIVAL AND DIFFERENTIATION OF A T(8;21) ACUTE MYELOID LEUKEMIA CELL LINE AND ARE MODULATED BY THE HDAC INHIBITOR D1 131
INCUBATION OF MURINE ERYTHROLEUKEMIA CELLS IN SEVERE HYPOXIA INDUCES MASSIVE APOPTOSIS PARALLELED BY AKT AND ERK5 CLEAVAGE 130
Targeting chronic myeloid leukemia stem cells with ERK5 pathway inhibitors 128
Butyrates as single drug induce histone acetylation and granulocytic maturation: possible selectivity on core binding factor-acute myeloid leukemia blasts. 128
SPECIFIC DEGRADATION OF THE AML1-ETO/COREPRESSOR COMPLEX BY A NOVEL ORAL HYDROXAMIC ACID DERIVATIVE 126
HDAC INHIBITORS IN COMBINATION WITH HYPOMETHYLATING AGENTS INDUCE SPECIFIC CHROMATIN MODIFICATION AND TRANSCRIPTIONAL ACTIVATION IN CBF/AML CELLS 123
EPIGENETIC MODIFICATIONS IN A T(8;21) ACUTE MYELOID LEUKEMIA CELL LINE CAUSED BY ADMINISTRATION OF THE HDAC INHIBITOR D1 120
ACETYLATION INDUCED BY BUTYRATES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA CAN LEAD TO DIFFENTIATION 110
Iron overload and iron chelation therapy in patients with myelodysplastic syndrome treated by allogeneic stem-cell transplantation: Report from the working conference on iron chelation of the Gruppo Italiano Trapianto di Midollo 106
Autologous haematopoietic stem cell transplantation affects long-term progression independent of relapse activity in aggressive multiple sclerosis: a comparative matched study 32
Totale 4.004
Categoria #
all - tutte 10.996
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.996


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021172 0 0 0 0 0 0 27 26 38 41 14 26
2021/2022171 9 12 14 9 2 6 3 12 2 13 34 55
2022/2023494 41 98 37 33 27 78 69 21 52 2 16 20
2023/2024201 10 17 24 8 15 19 9 58 3 4 19 15
2024/20251.337 44 132 99 193 424 244 3 51 36 47 33 31
2025/2026733 141 159 48 74 178 54 79 0 0 0 0 0
Totale 4.004